Madrigal Pharmaceuticals(MDGL) - 2024 Q3 - Earnings Call Presentation

Third-Quarter 2024 Financial Results October 31, 2024 Susan, NASH/MASH patient and advocate NASDAQ: MDGL © 2024 Madrigal Pharmaceuticals. All rights reserved. Forward-Looking Statements This presentation includes "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, that are based on Madrigal's beliefs and assumptions and on information currently available to it but are subject to factors beyond its control. Forward-looking statemen ...